Danijela Lucic

Abbott Molecular

Poster(s):

• (ID019) Alinity m HR HPV (IUO) Assay: Designed for Evolving Cervical Cancer Screening Programs
  Saturday, November 18, 2023

  9:15 AM – 10:15 AM MST

• (ID020) The Alinity m HR HPV Investigational Use Only (IUO) Assay: Designed for Management of Patients in Cervical Cancer Screening Programs
  Friday, November 17, 2023

  9:15 AM – 10:15 AM MST

• (ID022) Clinical Performance Characteristics of the Alinity m HR HPV (IUO) Assay Compared to COBAS and Aptima HPV Assays
  Friday, November 17, 2023

  9:15 AM – 10:15 AM MST

• (ID023) Prevalence of high-risk HPV genotypes in a large U.S. screening and enriched population
  Saturday, November 18, 2023

  9:15 AM – 10:15 AM MST

• (ID026) igh-risk HPV genotype distribution by cervical dysplasia severity in a large U.S. clinical study High-risk HPV genotype distribution by cervical dysplasia severity in a large U.S. clinical study
  Friday, November 17, 2023

  9:15 AM – 10:15 AM MST

• (ID069) Evaluation of Commercially Available HPV Panels with the Alinity m HR HPV Investigational Use Only (IUO) Assay
  Saturday, November 18, 2023

  9:15 AM – 10:15 AM MST